4.6 Review

Role of Gremlin in the Lung Development and Disease

Journal

Publisher

AMER THORACIC SOC
DOI: 10.1165/rcmb.2009-0101TR

Keywords

gremlin; pulmonary hypertension; bone morphogenetic protein

Funding

  1. Actelion
  2. Pfizer
  3. GlaxoSmithKline
  4. Lung Rx
  5. Sanofi

Ask authors/readers for more resources

Gremlin is an extracellular glycoprotein that was first identified over a decade ago through its important role in embryonic development, in which it acts as an antagonist of bone morphogenetic protein actions. It plays a critical role in the development of normal airways and the pulmonary circulation in the embryo. More recently, considerable evidence has been presented for a role for gremlin in the pathogenesis of lung diseases, particularly pulmonary hypertension and idiopathic pulmonary fibrosis. The purpose of this article is to review this evidence, consider the potential mechanisms and multicellular actions by which gremlin contributes to disease pathogenesis, and suggest future avenues of research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available